Editor | Curator

Advertisment

Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide

MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it...

Delic (DELCF) Announces C$7.0 Million Private Placement With Institutional Investor

NOT FOR DISSEMINATION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES/ VANCOUVER, BC, Sept. 23, 2021 /CNW/ - Delic Holdings Corp. ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0)...

PharmaTher (CSE: PHRM)Announces CAD$10 Million Private Placement With Institutional Investors

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”)...

Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company

WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First what it isn’t. In early August our research team...

Three Psychedelic Presentations Available Now: Filament Health (FLHLF), NovaMind (NVMDF) and Wesana Health (WSNAF)

Presentations Recorded September 16th Replays Available. Sign up for free registration to view presentations. https://youtu.be/e0ccytXLcEo The replays...

Braxia Scientific Reports Q1, Up 80% From Expanding Clinic Patient Base

Braxia Scientific Reports First Quarter 2022 Financial Results; Company Achieves 80% Revenue Growth from Expanding Clinic Patient Base Revenue from four Canadian clinics increased 80.3% to $407,075 year-over-yearExceeding monthly...

MindMed (MNMD) and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that Dr. Matthias...

Editor | Curator

Advertisment